Closed System Transfer Devices Market Scope And Analysis

Report Code : TIPRE00004560
Category : Life Sciences

No. of Pages : 150

Buy Now

Closed System Drug Transfer Device Market Scope and Analysis by 2031

Buy Now

Closed System Drug Transfer Device Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 789.54 Million
Market Size by 2031	US$ 3,509.73 Million
Global CAGR (2023 - 2031)	20.50%
Historical Data	2021-2022
Forecast period	2023-2031
Segments Covered	By Closing Mechanism Push-to-turn Systems Color-to-color Alignment Systems Luer-lock Systems Click-to-lock Systems By Type Membrane-to-membrane Systems Needleless Systems By Technology Diaphragm-based Devices Compartmentalized Devices Air Cleaning/Filtration Devices By Component Vial Access Devices Syringe Safety Devices Bag/Line Access Devices Accessories
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	BD B Braun Cardinal health Equashield LLC ICU Medical Carmel Pharma Hospira

Closed System Drug Transfer Device Market News and Recent Developments

The Closed System Drug Transfer Device Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for Closed System Drug Transfer Devices:

EQUASHIELD, a pioneer in closed system transfer devices (CSTDs) and automated pharmacy compounding solutions announced its remarkable achievement of being named by the Pharmacy Purchasing & Products as the most used device in the preparation and administration of hazardous drugs for five consecutive years. (Source: Equashield, Press Release/Company Website/Newsletter, August 2022)
B. Braun Medical Inc., a leading provider of closed system transfer devices (CSTD), announced today that the OnGuard 2 CSTD is now available in the United States. OnGuard 2 incorporates all of the current advantages of OnGuard, while offering upgraded materials and enhanced features to improve its usability. (Source: B. Braun Medical Inc, Press Release/Company Website/Newsletter, December 2021)

Closed System Drug Transfer Device Market Report Coverage and Deliverables

The “Closed System Drug Transfer Device Market Size and Forecast (2022–2030)” report provides a detailed analysis of the market covering below areas:

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Market dynamics such as drivers, restraints, and key opportunities
Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis
Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
Detailed company profiles